GE sells biopharma drug business to Danaher for $21.4 billion

February 25, 2019

(Reuters) – General Electric Co said on Monday it would sell its biopharma business to Danaher Corp for $21.4 billion, as the U.S. industrial conglomerate sheds non-core businesses to focus on its industrial unit.

Danaher develops technology for the dental, life sciences, diagnostics and environmental industries.

(Reporting by Ankit Ajmera in Bengaluru; Editing by Saumyadeb Chakrabarty)

Comments (No)

Leave a Reply